Next Century Growth Investors’s Edwards Lifesciences EW Stock Holding History

Next Century Growth Investors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,868	Closed	-$1.81M	–	110
2022 Q3	$1.81M	Sell	21,868 -15,159	-41%	-$1.46M	0.22%	79
2022 Q2	$3.52M	Buy	37,027 +122	+0.3%	+$12.6K	0.46%	57
2022 Q1	$4.34M	Sell	36,905 -1,528	-4%	-$171K	0.43%	69
2021 Q4	$4.98M	Sell	38,433 -28	-0.1%	-$3.27K	0.45%	67
2021 Q3	$4.35M	Sell	38,461 -12,558	-25%	-$1.43M	0.38%	86
2021 Q2	$5.28M	Buy	51,019 +4,116	+9%	+$388K	0.41%	74
2021 Q1	$3.92M	Buy	46,903 +10,988	+31%	+$929K	0.3%	93
2020 Q4	$3.28M	Buy	35,915 +10,417	+41%	+$864K	0.28%	98
2020 Q3	$2.04M	Sell	25,498 -3,137	-11%	-$245K	0.21%	105
2020 Q2	$1.98M	Hold	28,635	–	–	0.23%	103
2020 Q1	$1.8M	Hold	28,635	–	–	0.29%	90
2019 Q4	$2.23M	Sell	28,635 -1,509	-5%	-$118K	0.29%	92
2019 Q3	$2.21M	Sell	30,144 -13,395	-31%	-$941K	0.36%	82
2019 Q2	$2.68M	Sell	43,539 -2,250	-5%	-$136K	0.33%	85
2019 Q1	$2.92M	Buy	45,789 +27,225	+147%	+$1.55M	0.39%	86
2018 Q4	$947K	Sell	18,564 -11,436	-38%	-$579K	0.13%	113
2018 Q3	$1.74M	Sell	30,000 -15,372	-34%	-$752K	0.2%	117
2018 Q2	$2.2M	Hold	45,372	–	–	0.28%	106
2018 Q1	$2.11M	Sell	45,372 -28,551	-39%	-$1.24M	0.28%	98
2017 Q4	$2.78M	Sell	73,923 -10,845	-13%	-$398K	0.35%	79
2017 Q3	$3.09M	Sell	84,768 -7,182	-8%	-$274K	0.37%	86
2017 Q2	$3.62M	Sell	91,950 -26,871	-23%	-$981K	0.35%	87
2017 Q1	$3.73M	Sell	118,821 -6,822	-5%	-$214K	0.32%	91
2016 Q4	$3.92M	Sell	125,643 -4,056	-3%	-$131K	0.24%	97
2016 Q3	$5.21M	Buy	129,699 +48,030	+59%	+$1.81M	0.24%	118
2016 Q2	$2.71M	Buy	+81,669	New	+$2.79M	0.13%	142

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Next Century Growth Investors's EW Position: Q4 2022 in Review

Next Century Growth Investors sold out of Edwards Lifesciences (EW) in Q4 2022, closing a stake of 21,868 shares — an estimated $1.81M sold.

Next Century Growth Investors first reported a position in EW in Q2 2016 and held it in 26 quarters. The position peaked at $5.28M in Q2 2021. 1,228 funds tracked by Wall St. Rank hold EW as of Q4 2022.

Next Century Growth Investors reported no remaining Edwards Lifesciences position as of Q4 2022 after selling out during the quarter.
Next Century Growth Investors sold 21,868 Edwards Lifesciences shares in Q4 2022, an estimated $1.81M.
Next Century Growth Investors first reported a position in Edwards Lifesciences in Q2 2016 and held it in 26 quarters.
Next Century Growth Investors's Edwards Lifesciences position peaked at $5.28M in Q2 2021.
1,228 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Next Century Growth Investors's 13F filing for Q4 2022, filed 14 Feb 2023.